News

Fierce Pharma2h
Vinay Prasad is back at the FDA after last month's surprise ouster. Will he stay this time?
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
Fierce Pharma22h
Boehringer Ingelheim breaks into oncology with FDA approval for lung cancer med Hernexeos
With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer ...